| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |